Referenser

  1. Tournu G, Abramowitz L, Couffignal C, Juguet F, Sénéjoux A, Berger S, et al. Prevalence of anal symptoms in general practice: a prospective study. BMC Fam Pract. 2017;18(1):78.

  2. Riss S, Weiser FA, Schwameis K, Riss T, Mittlböck M, Steiner G, et al. The prevalence of hemorrhoids in adults. Int J Colorectal Dis. 2012;27(2):215-20.

  3. Alonso-Coello P, Guyatt G, Heels-Ansdell D, Johanson JF, Lopez-Yarto M, Mills E, et al. Laxatives for the treatment of hemorrhoids. Cochrane Database Syst Rev. 2005;2005(4):Cd004649.

  4. Kanellos I, Goulimaris I, Vakalis I, Dadoukis I. Long-term evaluation of sclerotherapy for haemorrhoids. A prospective study. Int J Surg Investig. 2000;2(4):295-8.

  5. Shanmugam V, Thaha MA, Rabindranath KS, Campbell KL, Steele RJ, Loudon MA. Rubber band ligation versus excisional haemorrhoidectomy for haemorrhoids. Cochrane Database Syst Rev. 2005;2005(3):Cd005034.

  6. Festen S, van Hoogstraten MJ, van Geloven AA, Gerhards MF. Treatment of grade III and IV haemorrhoidal disease with PPH or THD. A randomized trial on postoperative complications and short-term results. Int J Colorectal Dis. 2009;24(12):1401-5.

  7. Gupta PJ, Kalaskar S, Taori S, Heda PS. Doppler-guided hemorrhoidal artery ligation does not offer any advantage over suture ligation of grade 3 symptomatic hemorrhoids. Tech Coloproctol. 2011;15(4):439-44.

  8. Watson AJM, Hudson J, Wood J, Kilonzo M, Brown SR, McDonald A, et al. Comparison of stapled haemorrhoidopexy with traditional excisional surgery for haemorrhoidal disease (eTHoS): a pragmatic, multicentre, randomised controlled trial. The Lancet. 2016;388(10058):2375-85.

  9. Brown SR, Tiernan JP, Watson AJM, Biggs K, Shephard N, Wailoo AJ, et al. Haemorrhoidal artery ligation versus rubber band ligation for the management of symptomatic second-degree and third-degree haemorrhoids (HubBLe): a multicentre, open-label, randomised controlled trial. The Lancet. 2016;388(10042):356-64.

  10. Rincon-Cruz L, Staffa SJ, Dickie B, Nandivada P. Influence of Initial Treatment Strategy on Outcomes for Children With Rectal Prolapse. J Pediatr Gastroenterol Nutr. 2023;77(5):603-9.

  11. Svensk Gastroenterologisk förening. Riktlinjer perianal Crohns sjukdom. 2017.

  12. Lund JN, Scholefield JH. A randomised, prospective, double-blind, placebo-controlled trial of glyceryl trinitrate ointment in treatment of anal fissure. Lancet. 1997;349(9044):11-4.

  13. Nelson RL, Thomas K, Morgan J, Jones A. Non surgical therapy for anal fissure. Cochrane Database Syst Rev. 2012;2012(2):Cd003431.

  14. Nevins EJ, Kanakala V. Topical diltiazem and glyceryl-trinitrate for chronic anal fissure: A meta-analysis of randomised controlled trials. Turk J Surg. 2020;36(4):347-52.

  15. Sajid MS, Vijaynagar B, Desai M, Cheek E, Baig MK. Botulinum toxin vs glyceryltrinitrate for the medical management of chronic anal fissure: a meta-analysis. Colorectal Dis. 2008;10(6):541-6.

  16. Cevik M, Boleken ME, Koruk I, Ocal S, Balcioglu ME, Aydinoglu A, et al. A prospective, randomized, double-blind study comparing the efficacy of diltiazem, glyceryl trinitrate, and lidocaine for the treatment of anal fissure in children. Pediatr Surg Int. 2012;28(4):411-6.

  17. Husberg B, Malmborg P, Strigård K. Treatment with botulinum toxin in children with chronic anal fissure. Eur J Pediatr Surg. 2009;19(5):290-2.

  18. Sahnan K, Adegbola SO, Tozer PJ, Watfah J, Phillips RK. Perianal abscess. Bmj. 2017;356:j475.

  19. Sugrue J, Nordenstam J, Abcarian H, Bartholomew A, Schwartz JL, Mellgren A, et al. Pathogenesis and persistence of cryptoglandular anal fistula: a systematic review. Tech Coloproctol. 2017;21(6):425-32.

  20. Tozer PJ, Burling D, Gupta A, Phillips RK, Hart AL. Review article: medical, surgical and radiological management of perianal Crohn's fistulas. Aliment Pharmacol Ther. 2011;33(1):5-22.

  21. Lee MJ, Heywood N, Adegbola S, Tozer P, Sahnan K, Fearnhead NS, et al. Systematic review of surgical interventions for Crohn's anal fistula. BJS Open. 2017;1(3):55-66.

  22. Khodakaram K, Stark J, Höglund I, Andersson RE. Minimal Excision and Primary Suture is a Cost-Efficient Definitive Treatment for Pilonidal Disease with Low Morbidity: A Population-Based Interventional and a Cross-Sectional Cohort Study. World J Surg. 2017;41(5):1295-302.

  23. Pronk AA, Eppink L, Smakman N, Furnee EJB. The effect of hair removal after surgery for sacrococcygeal pilonidal sinus disease: a systematic review of the literature. Tech Coloproctol. 2018;22(1):7-14.

  24. Markell KW, Billingham RP. Pruritus Ani: Etiology and Management. Surgical Clinics of North America. 2010;90(1):125-35.

  25. Carrington EV, Popa SL, Chiarioni G. Proctalgia Syndromes: Update in Diagnosis and Management. Curr Gastroenterol Rep. 2020;22(7):35.

  26. Raine T, Bonovas S, Burisch J, Kucharzik T, Adamina M, Annese V, et al. ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment. J Crohns Colitis. 2022;16(1):2-17.

  27. van de Wetering FT, Verleye L, Andreyev HJ, Maher J, Vlayen J, Pieters BR, et al. Non-surgical interventions for late rectal problems (proctopathy) of radiotherapy in people who have received radiotherapy to the pelvis. Cochrane Database Syst Rev. 2016;4(4):Cd003455.

  28. Barton S, Wakefield V, O'Mahony C, Edwards S. Effectiveness of topical and ablative therapies in treatment of anogenital warts: a systematic review and network meta-analysis. BMJ Open. 2019;9(10):e027765.

  29. Omar MI, Alexander CE. Drug treatment for faecal incontinence in adults. Cochrane Database Syst Rev. 2013;2013(6):Cd002116.

  30. Maeda Y, Laurberg S, Norton C. Perianal injectable bulking agents as treatment for faecal incontinence in adults. Cochrane Database Syst Rev. 2013(2):Cd007959.

  31. Simillis C, Lal N, Pellino G, Baird D, Nikolaou S, Kontovounisios C, et al. A systematic review and network meta-analysis comparing treatments for faecal incontinence. Int J Surg. 2019;66:37-47.

  32. Luthra P, Camilleri M, Burr NE, Quigley EMM, Black CJ, Ford AC. Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol. 2019;4(11):831-44.

  33. Koh CE, Young CJ, Young JM, Solomon MJ. Systematic review of randomized controlled trials of the effectiveness of biofeedback for pelvic floor dysfunction. Br J Surg. 2008;95(9):1079-87.

  34. Regionala cancercentrum i samverkan. Koloncancer 2022 - Nationell kvalitetsrapport för år 2022 från Svenska Kolorektalcancerregistret. Umeå; 2022.

  35. Regionala cancercentrum i samverkan. Rektalcancer 2022 - Nationell kvalitetsrapport för år 2022 från Svenska Kolorektalcancerregistret. Umeå; 2022.

  36. Patel SG, Karlitz JJ, Yen T, Lieu CH, Boland CR. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection. Lancet Gastroenterol Hepatol. 2022;7(3):262-74.

  37. Bailey CE, Hu CY, You YN, Bednarski BK, Rodriguez-Bigas MA, Skibber JM, et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010. JAMA Surg. 2015;150(1):17-22.

  38. Regionala cancercentrum i samverkan. Nationellt vårdprogram tjock- och ändtarmscancer Umeå: Regionalt cancercentrum Norr; 2023 [Available from: https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/

  39. Regionala cancercentrum i samverkan. Standardiserat vårdförlopp tjock- och ändtarmscancer Stockholm: Regionala cancercentrum i samverkan; 2023 [Available from: https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardforlopp/

  40. Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA Cancer J Clin. 2017;67(2):93-9.

  41. Munro A, Brown M, Niblock P, Steele R, Carey F. Do Multidisciplinary Team (MDT) processes influence survival in patients with colorectal cancer? A population-based experience. BMC Cancer. 2015;15:686.

  42. Molenaar CJL, Minnella EM, Coca-Martinez M, Ten Cate DWG, Regis M, Awasthi R, et al. Effect of Multimodal Prehabilitation on Reducing Postoperative Complications and Enhancing Functional Capacity Following Colorectal Cancer Surgery: The PREHAB Randomized Clinical Trial. JAMA Surg. 2023;158(6):572-81.

  43. Oppedal K, Møller AM, Pedersen B, Tønnesen H. Preoperative alcohol cessation prior to elective surgery. Cochrane Database Syst Rev. 2012(7):Cd008343.

  44. Gustafsson UO, Scott MJ, Hubner M, Nygren J, Demartines N, Francis N, et al. Guidelines for Perioperative Care in Elective Colorectal Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations: 2018. World Journal of Surgery. 2019;43(3):659-95.

  45. Holm T. NPJ, Suzuki C., Szczegielniak S., Kordnejad S., Schmidt P. T., Blomqvist L., Martling A.,. Organsparande behandling vid rektalcancer – färre opereras. Läkartidningen. 2021;118.

  46. Hansdotter P, Scherman P, Petersen SH, Mikalonis M, Holmberg E, Rizell M, et al. Patterns and resectability of colorectal cancer recurrences: outcome study within the COLOFOL trial. BJS Open. 2021;5(4).

  47. Wille-Jørgensen P, Syk I, Smedh K, Laurberg S, Nielsen DT, Petersen SH, et al. Effect of More vs Less Frequent Follow-up Testing on Overall and Colorectal Cancer-Specific Mortality in Patients With Stage II or III Colorectal Cancer: The COLOFOL Randomized Clinical Trial. Jama. 2018;319(20):2095-103.

  48. Thorlacius H. SD, Backman A-S-., Palmqvist R., Toth E.,. Nya riktlinjer: endoskopisk kontroll efter kolorektal polypektomi. Läkartidningen. 2022;119.

  49. Keane C, Fearnhead NS, Bordeianou LG, Christensen P, Basany EE, Laurberg S, et al. International Consensus Definition of Low Anterior Resection Syndrome. Dis Colon Rectum. 2020;63(3):274-84.

  50. Strate LL, Morris AM. Epidemiology, Pathophysiology, and Treatment of Diverticulitis. Gastroenterology. 2019;156(5):1282-98.e1.

  51. Hughes LE. Postmortem survey of diverticular disease of the colon. I. Diverticulosis and diverticulitis. Gut. 1969;10(5):336-44.

  52. Wang FW, Chuang HY, Tu MS, King TM, Wang JH, Hsu CW, et al. Prevalence and risk factors of asymptomatic colorectal diverticulosis in Taiwan. BMC Gastroenterol. 2015;15:40.

  53. Loffeld RJ. Long-term follow-up and development of diverticulitis in patients diagnosed with diverticulosis of the colon. Int J Colorectal Dis. 2016;31(1):15-7.

  54. Shahedi K, Fuller G, Bolus R, Cohen E, Vu M, Shah R, et al. Long-term risk of acute diverticulitis among patients with incidental diverticulosis found during colonoscopy. Clin Gastroenterol Hepatol. 2013;11(12):1609-13.

  55. Delveus H, Lanzing G, Sahli H, Rönnow CF, Dahlbäck C, Buchwald P. Diverticulosis and risk of diverticulitis in 10 years; a Swedish retrospective observational study. Scand J Gastroenterol. 2024;59(4):433-6.

  56. Hinchey EJ, Schaal PG, Richards GK. Treatment of perforated diverticular disease of the colon. Adv Surg. 1978;12:85-109.

  57. Schultz JK, Azhar N, Binda GA, Barbara G, Biondo S, Boermeester MA, et al. European Society of Coloproctology: guidelines for the management of diverticular disease of the colon. Colorectal Dis. 2020;22 Suppl 2:5-28.

  58. Azhar N, Buchwald P, Ansari HZ, Schyman T, Yaqub S, Øresland T, et al. Risk of colorectal cancer following CT-verified acute diverticulitis: a nationwide population-based cohort study. Colorectal Dis. 2020;22(10):1406-14.

  59. Chabok A, Påhlman L, Hjern F, Haapaniemi S, Smedh K. Randomized clinical trial of antibiotics in acute uncomplicated diverticulitis. Br J Surg. 2012;99(4):532-9.

  60. Jalouta T, Jrebi N, Luchtefeld M, Ogilvie JW, Jr. Diverticulitis recurrence after percutaneous abscess drainage. Int J Colorectal Dis. 2017;32(10):1367-73.

  61. Buchwald P, Dixon L, Wakeman CJ, Eglinton TW, Frizelle FA. Hinchey I and II diverticular abscesses: long-term outcome of conservative treatment. ANZ J Surg. 2017;87(12):1011-4.

  62. Schultz JK, Yaqub S, Wallon C, Blecic L, Forsmo HM, Folkesson J, et al. Laparoscopic Lavage vs Primary Resection for Acute Perforated Diverticulitis: The SCANDIV Randomized Clinical Trial. Jama. 2015;314(13):1364-75.

  63. Angenete E, Thornell A, Burcharth J, Pommergaard HC, Skullman S, Bisgaard T, et al. Laparoscopic Lavage Is Feasible and Safe for the Treatment of Perforated Diverticulitis With Purulent Peritonitis: The First Results From the Randomized Controlled Trial DILALA. Ann Surg. 2016;263(1):117-22.

  64. Azhar N, Johanssen A, Sundström T, Folkesson J, Wallon C, Kørner H, et al. Laparoscopic Lavage vs Primary Resection for Acute Perforated Diverticulitis: Long-term Outcomes From the Scandinavian Diverticulitis (SCANDIV) Randomized Clinical Trial. JAMA Surg. 2021;156(2):121-7.

  65. Lambrichts DPV, Vennix S, Musters GD, Mulder IM, Swank HA, Hoofwijk AGM, et al. Hartmann's procedure versus sigmoidectomy with primary anastomosis for perforated diverticulitis with purulent or faecal peritonitis (LADIES): a multicentre, parallel-group, randomised, open-label, superiority trial. Lancet Gastroenterol Hepatol. 2019;4(8):599-610.

Föregående sida
Behandling

Nästa sida
Tillbaka till kapitlets första sida